PCN76 Cost-Effectiveness of Erlotinib as First-Line Maintenance Therapy for Advanced Non-Small-Cell Lung Carcinoma in Patients EGFR WT and Stable Disease After Four Cycles of Chemotherapy
Nov 1, 2012, 00:00
10.1016/j.jval.2012.08.2116
https://www.valueinhealthjournal.com/article/S1098-3015(12)03830-2/fulltext
Title :
PCN76 Cost-Effectiveness of Erlotinib as First-Line Maintenance Therapy for Advanced Non-Small-Cell Lung Carcinoma in Patients EGFR WT and Stable Disease After Four Cycles of Chemotherapy
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(12)03830-2&doi=10.1016/j.jval.2012.08.2116
First page :
A422
Section Title :
Cancer
Open access? :
No
Section Order :
769